Cargando…

Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis

BACKGROUND: Reports have suggested a reduction in exacerbations of chronic obstructive pulmonary disease (COPD) during the coronavirus disease 2019 (COVID-19) pandemic, particularly hospital admissions for severe exacerbations. However, the magnitude of this reduction varies between studies. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqahtani, Jaber S., Oyelade, Tope, Aldhahir, Abdulelah M., Mendes, Renata Gonçalves, Alghamdi, Saeed M., Miravitlles, Marc, Mandal, Swapna, Hurst, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330941/
https://www.ncbi.nlm.nih.gov/pubmed/34343205
http://dx.doi.org/10.1371/journal.pone.0255659
_version_ 1783732829385916416
author Alqahtani, Jaber S.
Oyelade, Tope
Aldhahir, Abdulelah M.
Mendes, Renata Gonçalves
Alghamdi, Saeed M.
Miravitlles, Marc
Mandal, Swapna
Hurst, John R.
author_facet Alqahtani, Jaber S.
Oyelade, Tope
Aldhahir, Abdulelah M.
Mendes, Renata Gonçalves
Alghamdi, Saeed M.
Miravitlles, Marc
Mandal, Swapna
Hurst, John R.
author_sort Alqahtani, Jaber S.
collection PubMed
description BACKGROUND: Reports have suggested a reduction in exacerbations of chronic obstructive pulmonary disease (COPD) during the coronavirus disease 2019 (COVID-19) pandemic, particularly hospital admissions for severe exacerbations. However, the magnitude of this reduction varies between studies. METHOD: Electronic databases were searched from January 2020 to May 2021. Two independent reviewers screened titles and abstracts and, when necessary, full text to determine if studies met inclusion criteria. A modified version of the Newcastle-Ottawa Scale was used to assess study quality. A narrative summary of eligible studies was synthesised, and meta-analysis was conducted using a random effect model to pool the rate ratio and 95% confidence intervals (95% CI) for hospital admissions. Exacerbation reduction was compared against the COVID-19 Containment and Health Index. RESULTS: A total of 13 of 745 studies met the inclusion criteria and were included in this review, with data from nine countries. Nine studies could be included in the meta-analysis. The pooled rate ratio of hospital admissions for COPD exacerbations during the pandemic period was 0.50 (95% CI 0.44–0.57). Findings on the rate of community-treated exacerbations were inconclusive. Three studies reported a significant decrease in the incidence of respiratory viral infections compared with the pre-pandemic period. There was not a significant relationship between exacerbation reduction and the COVID-19 Containment and Health Index (rho = 0.20, p = 0.53). CONCLUSION: There was a 50% reduction in admissions for COPD exacerbations during the COVID-19 pandemic period compared to pre-pandemic times, likely associated with a reduction in respiratory viral infections that trigger exacerbations. Future guidelines should consider including recommendations on respiratory virus infection control measures to reduce the burden of COPD exacerbations beyond the pandemic period.
format Online
Article
Text
id pubmed-8330941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83309412021-08-04 Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis Alqahtani, Jaber S. Oyelade, Tope Aldhahir, Abdulelah M. Mendes, Renata Gonçalves Alghamdi, Saeed M. Miravitlles, Marc Mandal, Swapna Hurst, John R. PLoS One Research Article BACKGROUND: Reports have suggested a reduction in exacerbations of chronic obstructive pulmonary disease (COPD) during the coronavirus disease 2019 (COVID-19) pandemic, particularly hospital admissions for severe exacerbations. However, the magnitude of this reduction varies between studies. METHOD: Electronic databases were searched from January 2020 to May 2021. Two independent reviewers screened titles and abstracts and, when necessary, full text to determine if studies met inclusion criteria. A modified version of the Newcastle-Ottawa Scale was used to assess study quality. A narrative summary of eligible studies was synthesised, and meta-analysis was conducted using a random effect model to pool the rate ratio and 95% confidence intervals (95% CI) for hospital admissions. Exacerbation reduction was compared against the COVID-19 Containment and Health Index. RESULTS: A total of 13 of 745 studies met the inclusion criteria and were included in this review, with data from nine countries. Nine studies could be included in the meta-analysis. The pooled rate ratio of hospital admissions for COPD exacerbations during the pandemic period was 0.50 (95% CI 0.44–0.57). Findings on the rate of community-treated exacerbations were inconclusive. Three studies reported a significant decrease in the incidence of respiratory viral infections compared with the pre-pandemic period. There was not a significant relationship between exacerbation reduction and the COVID-19 Containment and Health Index (rho = 0.20, p = 0.53). CONCLUSION: There was a 50% reduction in admissions for COPD exacerbations during the COVID-19 pandemic period compared to pre-pandemic times, likely associated with a reduction in respiratory viral infections that trigger exacerbations. Future guidelines should consider including recommendations on respiratory virus infection control measures to reduce the burden of COPD exacerbations beyond the pandemic period. Public Library of Science 2021-08-03 /pmc/articles/PMC8330941/ /pubmed/34343205 http://dx.doi.org/10.1371/journal.pone.0255659 Text en © 2021 Alqahtani et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Alqahtani, Jaber S.
Oyelade, Tope
Aldhahir, Abdulelah M.
Mendes, Renata Gonçalves
Alghamdi, Saeed M.
Miravitlles, Marc
Mandal, Swapna
Hurst, John R.
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title_full Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title_fullStr Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title_full_unstemmed Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title_short Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
title_sort reduction in hospitalised copd exacerbations during covid-19: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330941/
https://www.ncbi.nlm.nih.gov/pubmed/34343205
http://dx.doi.org/10.1371/journal.pone.0255659
work_keys_str_mv AT alqahtanijabers reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT oyeladetope reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT aldhahirabdulelahm reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT mendesrenatagoncalves reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT alghamdisaeedm reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT miravitllesmarc reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT mandalswapna reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis
AT hurstjohnr reductioninhospitalisedcopdexacerbationsduringcovid19asystematicreviewandmetaanalysis